A machine learning model developed using Indian data demonstrates higher accuracy compared to conventional risk scores.

Interpretation & Adoption Message

AI Algorithm + Clinicians: This risk assessment tool has been built as an adjunct tool for physicians to identify global/holistic risk for Liver Fibrosis in NAFLD patients.
Risk Identification and Prevention: This Risk Assessment Tool should not be used to diagnose Liver Fibrosis. Its limitations include already-diagnosed Liver fibrosis and currently under treatment.
Where to use: This risk assessment tool has been prepared for use in Preventive Gastroenterology and Liver Disease Screening programs at Outpatient Clinics, Emergency Rooms, and Health Check Clinics, specifically those focusing on Non-Alcoholic Fatty Liver Disease.

Apollo Hospitals AILF

by Apollo Hospitals Enterprise Ltd